Large-cap Health Care company UnitedHealth has moved -0.7% so far today on a volume of 3,462,153, compared to its average of 2,833,207. In contrast, the S&P 500 index moved 1.0%.
UnitedHealth trades -7.48% away from its average analyst target price of $591.39 per share. The 23 analysts following the stock have set target prices ranging from $500.0 to $660.0, and on average have given UnitedHealth a rating of buy.
If you are considering an investment in UNH, you'll want to know the following:
-
UnitedHealth has moved 2.0% over the last year, and the S&P 500 logged a change of 14.0%
-
Based on its trailing earnings per share of 23.04, UnitedHealth has a trailing 12 month Price to Earnings (P/E) ratio of 23.7 while the S&P 500 average is 15.97
-
UNH has a forward P/E ratio of 19.6 based on its forward 12 month price to earnings (EPS) of $27.93 per share
-
The company has a price to earnings growth (PEG) ratio of 1.74 — a number near or below 1 signifying that UnitedHealth is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 5.99 compared to its sector average of 4.08
-
UnitedHealth Group Incorporated operates as a diversified health care company in the United States.
-
Based in Minnetonka, the company has 400,000 full time employees and a market cap of $506.08 Billion. UnitedHealth currently returns an annual dividend yield of 1.3%.